93 22 75

Pill imprint 93 22 75 has been identified as Amoxicillin and clavulanate 875 mg / 125 mg.

Amoxicillin/clavulanate is used in the treatment of urinary tract infection; upper respiratory tract infection; bronchitis; sinusitis; bacterial infection (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy.

Amoxicillin/clavulanate 875 mg / 125 mg is not subject to the Controlled Substances Act.
See also related documents.

Amoxicillin and clavulanate Images

Imprint:
93
22 75
Strength:
875 mg / 125 mg
Color:
White
Size:
22.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
titanium dioxide
triacetin
Drug Class:
Beta-lactamase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-2275
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5471 A S Medication Solutions LLC (repackager)
55045-2966 Dispensing Solutions Inc. (repackager)
54868-4951 Physicians Total Care Inc (repackager)
55887-0629 Diversified Healthcare Services Inc (repackager)
68115-0463 Dispensexpress Inc (repackager)
21695-0215 Rebel Distributors Corp (repackager)
10544-0370 Blenheim Pharmacal Inc (repackager)
66267-0712 Nucare Pharmaceuticals Inc (repackager)
53002-0789 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Amoxicillin and clavulanate 875 mg / 125 mg 93 22 75
Amoxicillin and clavulanate 875 mg / 125 mg 93 22 75
Amoxicillin and clavulanate 875 mg / 125 mg 93 22 75
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)